Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is V  [Clear All Filters]
Ditadi A, Sankaran VG. Vade-MECOM: How to peel back the layers of hematopoiesis. Cell Stem Cell. 2022;29(11):1512-1514.
Quan L-Q, Wang Y, Tang J-X, Zhou Y, Liao C-C, Liu D, Zhao X-D, Li R-T, Li H-M. Valeridoids G - Q, Eleven seco-Iridoids from Valeriana jatamansi and Their Bioactivites. Chem Biodivers. 2022:e202200609.
Rathod SN, Bardowski L, Tse I, Churyla A, Fiehler M, Malczynski M, Qi C, Tanna SD, Bulger C, Al-Qamari A, et al. Vancomycin-resistant Enterococcus (VRE) outbreak in a Pre- and Post-cardiothoracic transplant population: impact of discontinuing Multidrug-resistant organism (MDRO) Surveillance during the COVID-19 pandemic. Transpl Infect Dis. 2022.
Peng L, Renauer PA, Ökten A, Fang Z, Park JJ, Zhou X, Lin Q, Dong MB, Filler R, Xiong Q, et al. Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2. Cell Rep Med. 2022:100634.
Kumar V, Pouw RB, Autio MI, Sagmeister MG, Phua ZYang, Borghini L, Wright VJ, Hoggart C, Pan B, Tan AKiat Yee, et al. Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations. Am J Hum Genet. 2022.
Traoré M, Kaal J, Cortizas AMartínez. Variation of wood color and chemical composition in the stem cross-section of oak (Quercus spp.) trees, with special attention to the sapwood-heartwood transition zone. Spectrochim Acta A Mol Biomol Spectrosc. 2022;285:121893.
Jiang F, Zhou H, Cheng Y, He Z, Meng P, Sun K, Wang P, Han X, Wang L, Yang M, et al. Various detailed characteristics of a new enhanced neurotrophic factor secreting rat derived bone marrow mesenchymal stem cells and its preliminary application in rat models of ischemic stroke. Exp Cell Res. 2022:113140.
Chupradit S, Nasution MKm, Rahman HSulaiman, Suksatan W, Jalil ATurki, Abdelbasset WK, Bokov D, Markov A, Fardeeva IN, Widjaja G, et al. Various types of electrochemical biosensors for leukemia detection and therapeutic approaches. Anal Biochem. 2022:114736.
Orlova VV, Nahon DM, Cochrane A, Cao X, Freund C, van den Hil F, Westermann CJJ, Snijder RJ, van Amstel JKristian P, Dijke PTen, et al. Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip. Stem Cell Reports. 2022.
Rashidi A, Theruvath AJ, Huang C-H, Wu W, Mahmoud EE, Raj JGerald Jes, Marycz K, Daldrup-Link HE. Vascular injury of immature epiphyses impair stem cell engraftment in cartilage defects. Sci Rep. 2022;12(1):11696.
Liang Q, Liang C, Liu X, Xing X, Ma S, Huang H, Liang C, Liu L, Liao L, Tian W. Vascularized dental pulp regeneration using cell-laden microfiber aggregates. J Mater Chem B. 2022.
Ichijo R, Maki K, Kabata M, Murata T, Nagasaka A, Ishihara S, Haga H, Honda T, Adachi T, Yamamoto T, et al. Vasculature atrophy causes a stiffened microenvironment that augments epidermal stem cell differentiation in aged skin. Nat Aging. 2022;2(7):592-600.
Ma X, Wang Y, Liu Q, Han B, Wang G, Zhang R, Huang X, Wang X, Yang M, Xing C, et al. Vaspin alleviates the lncRNA LEF1-AS1-induced osteogenic differentiation of vascular smooth muscle cells via the Hippo/YAP signaling pathway. Exp Cell Res. 2022:113407.
Hatori A, Fujii Y, Kawase-Koga Y, Ogasawara T, Chikira J, Minami S, Yamakawa D, Chikazu D. VCAM-1 and GFPT-2: Predictive markers of osteoblast differentiation in human dental pulp stem cells. Bone. 2022:116575.
Gupta S, Gangenahalli G. VCAM1 Mediated Targeting of Human Hematopoietic Stem Cells to Bone Marrow is Effective in Conferring Regeneration and Survival in Lethally Irradiated Mice. Transplant Cell Ther. 2022.
Balachandar M, Ravi RKoshila, Muthukumar T. Vegetative anatomy and endorrhizal fungal morphology of an endangered medicinal plant Gloriosa superba L. Microsc Res Tech. 2022.
Mitra S, Devi S, Lee M-S, Jui J, Sahu A, Goldman D. Vegf signaling between Müller glia and vascular endothelial cells is regulated by immune cells and stimulates retina regeneration. Proc Natl Acad Sci U S A. 2022;119(50):e2211690119.
Daver NG, Dail M, Garcia JS, Jonas BA, Yee KWL, Kelly KR, Vey N, Assouline S, Roboz GJ, Paolini S, et al. Venetoclax and idasanutlin in relapsed/refractory AML: a non-randomized, open-label phase 1b trial. Blood. 2022.
Lachowiez CA, Reville PK, Kantarjian H, Jabbour E, Borthakur G, Daver N, Loghavi S, Furudate K, Xiao L, Pierce S, et al. Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study. Lancet Haematol. 2022;9(5):e350-e360.
Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, et al. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022.
Kwag D, Cho B-S, Bang S-Y, Lee JHyuk, Min G-J, Park S-S, Park S, Yoon J-H, Lee S-E, Eom K-S, et al. Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood Cancer J. 2022;12(12):169.
Juliusson G. Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia. Lancet Haematol. 2022;9(5):e317-e318.